Australia Infant Phototherapy Device Market Size and Forecast 2025–2033
The Australia Infant Phototherapy Device Market is projected to grow from US$ 1.88 billion in 2024 to approximately US$ 2.47 billion by 2033, expanding at a CAGR of 3.1% during 2025–2033. This growth is primarily driven by increasing cases of neonatal jaundice, improvements in neonatal healthcare infrastructure, rising awareness of early-life medical conditions, and advances in non-invasive phototherapy technologies. Hospitals and neonatal intensive care units (NICUs) across the country continue adopting modern LED-based phototherapy systems due to their safety, efficiency, and ability to reduce heat exposure for infants.
Full Access Report:https://www.renub.com/australia-infant-phototherapy-device-market-p.php
Australia Infant Phototherapy Device Market Outlooks
Infant phototherapy devices are used to treat neonatal jaundice, a common medical condition caused by elevated bilirubin levels in newborns. These devices emit controlled blue light wavelengths (typically 460–490 nm), enabling the bilirubin to break down and pass safely from the infant's system. The treatment is widely recognized as safe, painless, and highly effective when administered early.
Australia has a strong healthcare network, which ensures neonatal screening immediately after birth. Hospitals, maternity centers, and specialized neonatal clinics commonly use phototherapy devices as part of first-line treatment. The increasing preference for LED phototherapy systems in Australia is because they consume less power, last longer, minimize heat exposure, and maintain stable light output. Moreover, parental awareness regarding the risks of unmanaged jaundice has improved, encouraging early treatment and ensuring wider adoption of advanced phototherapy solutions.
Growth Drivers in the Australia Infant Phototherapy Device Market
Increasing Prevalence of Neonatal Jaundice
Neonatal jaundice affects a significant portion of newborn infants within the first few days of life. It is more common in premature babies due to underdeveloped liver function. The Australian healthcare system mandates early screening after birth, which has increased the detection of jaundice cases. As diagnosis improves, so does the need for high-performance phototherapy units.
According to the Australian Bureau of Statistics, approximately 289,100 births were recorded in 2023, representing a strong and consistent newborn population requiring access to neonatal services. Increased awareness among parents, midwives, and healthcare professionals continues to support the steady use of phototherapy devices nationwide.
Advances in Phototherapy Device Technology
Technological innovation plays a central role in market expansion. Traditional fluorescent-based devices are gradually being replaced by LED phototherapy systems, which offer:
· Lower heat emissions
· Better comfort and safety
· Longer device lifespan
· Greater light intensity control
· Improved therapeutic efficiency
In addition, fiber-optic phototherapy blankets allow infants to remain swaddled and held by caregivers during treatment, improving emotional bonding and reducing stress.
Healthcare equipment manufacturers continue to introduce devices tailored for NICUs, maternity wards, and even supervised home care settings. For instance, in March 2022, Cook Medical launched the MINC+ Benchtop Incubator for IVF and perinatal environments, signaling broader investment in newborn wellness and neonatal technologies across Australia.
Supportive Government Healthcare Policies
Australia’s government provides strong support for maternal and infant healthcare under both public and private medical frameworks. Newborn screening programs, hospital funding, staff training initiatives, and procurement support ensure widespread access to phototherapy systems. Government-backed neonatal improvement strategies also encourage upgrading of outdated systems, particularly in regional and remote medical centers.
👉 Want to explore detailed market trends, segment insights, and forecasts? 🔗 Request Sample Report:https://www.renub.com/request-sample-page.php?gturl=australia-infant-phototherapy-device-market-p.php
Challenges in the Australia Infant Phototherapy Device Market
High Cost of Advanced Equipment
While LED and fiber-optic devices offer clear safety and performance benefits, they come at a higher upfront cost. Small clinics, birthing centers, and remote medical facilities with limited budgets may continue relying on aging fluorescent systems. The absence of centralized equipment procurement in certain regions results in uneven access and delayed adoption of modern neonatal care systems.
Limited Availability in Remote and Indigenous Communities
Australia’s vast geography presents challenges in delivering equal healthcare access. Remote and Indigenous communities often lack specialized neonatal facilities, requiring infants to be transported to major hospitals for phototherapy treatment. These delays can increase health risks. Mobile and portable phototherapy devices are therefore gaining importance to improve neonatal outcomes in underserved regions.
Australia Infant Phototherapy Fluorescent Lamps Device Market
Fluorescent phototherapy devices were historically the most common treatment system. They are cost-effective upfront but require frequent maintenance and bulb replacements, generate higher heat levels, and offer lower efficiency compared to LED models. Their use continues in certain smaller clinics and budget-constrained facilities, but the segment is expected to decline steadily as LED systems become standard.
Australia Infant Phototherapy Mobile Device Market
Mobile phototherapy systems offer flexibility and are increasingly used in maternity units requiring fast room-to-room transfer capability, as well as in community outreach programs. Their portability also enables treatment in supervised home-care environments, helping avoid unnecessary hospital admissions. As Australia continues prioritizing decentralized neonatal care, demand for portable and mobile phototherapy units is expected to rise.
Australia Infant Phototherapy Fixed Device Market
Fixed phototherapy devices are designed for high-capacity usage in NICUs and hospitals treating several newborn patients. They provide continuous, stable light output, are built for durability, and are ideal for high-traffic neonatal units. Urban and metropolitan hospitals with well-established maternity services remain key purchasers of fixed systems.
Australia Infant Phototherapy Device Hospital Market
Hospitals represent the largest end user segment for phototherapy devices in Australia. Public and private hospitals invest in high-efficiency phototherapy equipment to ensure early jaundice management and reduce neonatal readmission rates. Continuous upgrades, staff training, and policy-driven neonatal safety improvements support this segment’s dominance.
Regional Market Insights
Victoria Infant Phototherapy Device Market
Victoria, particularly Melbourne, has a high density of advanced neonatal centers. Continuous investment in modern equipment and strong maternal healthcare programs support above-average adoption of LED and fiber-optic phototherapy systems.
Queensland Infant Phototherapy Device Market
Queensland’s vast geographic distribution requires both fixed and mobile devices to address urban and remote population needs. Major hospitals in Brisbane and Cairns complement outreach services and remote facility support, fueling hybrid demand.
Tasmania Infant Phototherapy Device Market
Tasmania maintains strong neonatal care facilities despite its smaller population. Hobart and Launceston hospitals use advanced phototherapy equipment, while mobile units support smaller towns and rural areas.
Western Australia Infant Phototherapy Device Market
Western Australia, with remote Aboriginal populations, places strong emphasis on outreach neonatal care. Mobile and portable devices play a critical role in extending treatment access beyond Perth’s concentrated hospital network.
Market Segmentation
Light Source
· Fluorescent Lamps
· Light Emitting Diodes
· Quartz Halogen Lamps
· Gas Discharge Tubes
Configuration
· Mobile Device
· Fixed Device
End User
· Hospital
· Neonatal Clinics
Top States
· New South Wales
· Victoria
· Queensland
· Western Australia
· South Australia
· Australian Capital Territory
· Tasmania
· Northern Territory
Key Players
· Ningbo David Medical Device Co., Ltd
· Koninklijke Philips N.V.
· General Electric Company
· Inspiration Healthcare Group Plc
· Drägerwerk AG & Co. KGaA
· Ibis Medical Equipment and Systems Pvt Ltd
· Weyer GmbH
· Natus Medical Incorporated
· Note: If you need details, data, or insights not covered in this report, we are glad to assist. Through our customization service, we will collect and deliver the information you require, tailored to your specific needs. Share your requirements with us, and we will update the report to align with your expectations.